Séquences d'ADN codant des polypeptides avec activité béta-1,3-glucanase

European patent · EP0353191 · Deleted

Register entry

Publication number
EP0353191
Application number
EP89810555
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 20, 1989
Published
Jan 31, 1990
Granted
Dec 4, 1996
Deleted
Jul 19, 2009
Reason
Maximum term reached
IPC classes
C12N 15/56 (2006.01)
C12N 9/24 (2006.01)
C12P 21/02 (2006.01)
Priority
US 226303 29.07.1988
US 353312 17.05.1989
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 27, 2009

    Maximum term reached

    Published in Swissreg on 27.07.2009

  2. Mar 31, 2003

    Transferred

    Owner
    Novartis AG, Schwarzwaldallee 215, 4058 Basel → Syngenta Participations AG, Schwarzwaldallee 215, 4058 Basel

    Published in +pat+ No 6 in 2003

  3. Feb 14, 1997

    Address changed

    Owner
    CIBA-GEIGY AG, Klybeckstrasse 141, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 3 in 1997

  4. Dec 13, 1996

    Granted

    Published in PIDTJ No 23 in 1996

Parties

Inventor

Meins, Frederick, Prof.

CH-4125 Riehen

Shinshi, Hideaki

Tsuchinra City Ibaraki 300, JP

Wenzler, Herman C.

Texas 77840-5201, US

Hofsteenge, Jan, Dr.

CH-4153 Reinach

Ryals, John, Dr.

Durham, NC 27713, US

Sperisen Christoph

CH-4056 Basle

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.